August 12, 2021
1 min watch
Cyclosporine insert removes compliance issue from dry eye disease treatment
[ad_1]
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Lee Shettle, DO, discusses results from a phase 1 trial investigating a novel hydrogel-based cyclosporine insert for the treatment of dry eye disease.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
American Society of Cataract and Refractive Surgery Meeting
[ad_2]
Source link
